- Home
- PRAX vs LX Comparison
PRAX vs LX Comparison
Compare PRAX & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- LX
- Stock Information
- Founded
- PRAX 2015
- LX 2013
- Country
- PRAX United States
- LX China
- Employees
- PRAX N/A
- LX N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- LX Finance: Consumer Services
- Sector
- PRAX Health Care
- LX Finance
- Exchange
- PRAX Nasdaq
- LX Nasdaq
- Market Cap
- PRAX 952.1M
- LX 1.1B
- IPO Year
- PRAX 2020
- LX 2017
- Fundamental
- Price
- PRAX $52.00
- LX $5.08
- Analyst Decision
- PRAX Strong Buy
- LX
- Analyst Count
- PRAX 10
- LX 0
- Target Price
- PRAX $93.30
- LX N/A
- AVG Volume (30 Days)
- PRAX 435.3K
- LX 2.8M
- Earning Date
- PRAX 11-05-2025
- LX 11-24-2025
- Dividend Yield
- PRAX N/A
- LX 7.72%
- EPS Growth
- PRAX N/A
- LX 86.38
- EPS
- PRAX N/A
- LX 1.28
- Revenue
- PRAX $7,765,000.00
- LX $1,956,013,429.00
- Revenue This Year
- PRAX N/A
- LX $6.40
- Revenue Next Year
- PRAX $20.00
- LX $17.75
- P/E Ratio
- PRAX N/A
- LX $4.15
- Revenue Growth
- PRAX 338.45
- LX 0.80
- 52 Week Low
- PRAX $26.70
- LX $2.63
- 52 Week High
- PRAX $91.83
- LX $11.64
- Technical
- Relative Strength Index (RSI)
- PRAX 56.68
- LX 33.01
- Support Level
- PRAX $46.99
- LX $5.27
- Resistance Level
- PRAX $55.86
- LX $5.79
- Average True Range (ATR)
- PRAX 3.62
- LX 0.21
- MACD
- PRAX 0.56
- LX -0.02
- Stochastic Oscillator
- PRAX 74.41
- LX 0.14
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.